Fraser Aileen, Cairnes Vida, Mikkelsen Else, Knellwolf Christina, Locher Regula, Andersson Marie
University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Department of Gastroenterology, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.
Nurs Open. 2025 Apr;12(4):e70191. doi: 10.1002/nop2.70191.
To provide evidence-based guidance on practical aspects and potential safety concerns (infusion reactions and hypophosphataemia) related to the use of intravenous iron from a nursing perspective.
A modified Delphi consensus method.
Literature searches were conducted and used to support the development of 16 consensus statements. Six nurses with expertise in the field of gastroenterology and experience with the administration of intravenous iron participated in a modified Delphi process to develop a final set of statements.
Overall, 16 statements achieved consensus and covered the practicalities of administration, infusion reactions and hypophosphataemia. Patient preparation is a key step in the administration of intravenous iron, but information should be communicated carefully to prevent undue anxiety. Highlighting the nurse's confidence in the management of any reactions may help to reduce anxiety. The patient should be observed during the first 5-10 min of an infusion to allow prompt management of immediate infusion reactions, although severe hypersensitivity reactions are rare. Nurses should be vigilant for symptoms of hypophosphataemia (such as fatigue, weakness and muscle/bone pain), which can develop following treatment with ferric carboxymaltose, saccharated ferric oxide and iron polymaltose. Serum phosphate levels should be measured in patients receiving ferric carboxymaltose who are at risk of low phosphate.
Infusion reactions and hypophosphataemia with intravenous iron are documented in the literature, but existing publications do not approach these topics from a nursing perspective. This consensus paper highlights the importance of patient preparation, monitoring and prompt management when administering intravenous iron to ensure patient safety. Considering that nurses have a central role in the administration of intravenous iron, the availability of evidence-based guidance is essential for both nurse confidence and patient safety.
No patient or public contribution was involved in the consensus process.
从护理角度为静脉注射铁剂使用的实际操作及潜在安全问题(输液反应和低磷血症)提供循证指导。
改良德尔菲共识法。
进行文献检索并用于支持16条共识声明的制定。6名在胃肠病学领域有专长且有静脉注射铁剂给药经验的护士参与了改良德尔菲过程,以制定最终的声明集。
总体而言,16条声明达成共识,涵盖给药的实际操作、输液反应和低磷血症。患者准备是静脉注射铁剂给药的关键步骤,但信息传达应谨慎,以防止过度焦虑。强调护士对任何反应管理的信心可能有助于减轻焦虑。尽管严重过敏反应罕见,但在输液的前5 - 10分钟应观察患者,以便及时处理即刻发生的输液反应。护士应警惕低磷血症的症状(如疲劳、虚弱和肌肉/骨痛),这些症状可能在接受羧基麦芽糖铁、含糖氧化铁和聚麦芽糖铁治疗后出现。对于有低磷风险的接受羧基麦芽糖铁治疗的患者,应检测血清磷酸盐水平。
文献中记录了静脉注射铁剂的输液反应和低磷血症,但现有出版物未从护理角度探讨这些主题。这篇共识论文强调了静脉注射铁剂给药时患者准备、监测和及时处理的重要性,以确保患者安全。考虑到护士在静脉注射铁剂给药中起核心作用,循证指导的可用性对于护士的信心和患者安全至关重要。
共识过程未涉及患者或公众参与。